Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARTEST phase 3 enobosarm versus active control in AR+/ER+/HER2- metastatic breast cancer
2021-002176-39Phase 3Active
- Sponsor
- Veru Inc.
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of enobosarm in breast cancer (2 arms), sponsored by Veru Inc. Primary endpoint: Radiographic progression-free survival. Started Dec 2021; status: active.
02
Drugs
enobosarm
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2021-002176-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-002176-39.